Weekly Clinical Updates

Trial Stops Enrollment after Tpoxx Fails to Speed Clade 2 Mpox Healing or Pain Relief | Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea

Estimated Effectiveness of Influenza Vaccines | Benefit of Early Oseltamivir Therapy for Adults | Maternal Infection of SARS-CoV-2 | The Effect of Pre-COVID and Post-COVID Vaccination | Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies | Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations | Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission | Transcutaneous Electrical Nerve Stimulation for Fibromyalgia-like Syndrome | Mitigating the Risks of Post-acute Sequelae of SARS-CoV-2 Infection | Measurement of Circulating Viral Antigens Post-SARS-CoV-2 Infection

Association between Use of a Voluntary Isolation Centre and Reduced Household SARS-CoV-2 Transmission | Risks of SARS-CoV-2 JN.1 Infection and COVID-19–Associated Emergency Department Visits | Real Clinical Effectiveness of Molnupiravir against 30-day Mortality | Time to Sustained Recovery Among Outpatients With COVID-19 | Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 | Remdesivir for 5 or 10 Days in Patients | Remdesivir for Treatment of COVID-19 | Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-age Adults

Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022 | N95 Filtering Facepiece Respirator Reuse, Extended Use, and Filtration Efficiency | Enhanced Placental Antibody Transfer Efficiency with Longer Interval Between Maternal RSV Vaccination and Birth

Real-world Effectiveness of Nirmatrelvir-Ritonavir and Molnupiravir in Non-hospitalised Adults with Covid-19: A Population-based, Retrospective Cohort Study (sic) Cohort Study | Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated with Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial | Post-acute Sequelae of SARS-CoV-2 Cardiovascular Symptoms are Associated with Trace-level Cytokines that Affect Cardiomyocyte Function

Symptoms Six Weeks After COVID-19 are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021–April 2022 | Microbial Dynamics and Pulmonary Immune Responses in COVID-19 Secondary Bacterial Pneumonia | Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19